Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $897K invested in Kazia Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
428% more capital invested
Capital invested by funds: $170K → $897K (+$727K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$296K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$115K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$61.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.2K |
| 5 |
Citigroup
New York
|
+$3.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$93.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$31K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.87K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $444K | +$296K | +516 | New |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $172K | +$115K | +200 | New |
|
|
3
Jane Street
New York
| $105K | -$93.5K | -163 | -57% |
|
|
CS
4
Credit Suisse
Zurich,
Switzerland
| $92K | +$61.4K | +107 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $43K | +$25.2K | +44 | +733% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $17K | -$2.87K | -5 | -20% |
|
7
Morgan Stanley
New York
| $12K | +$1.15K | +2 | +17% |
|
|
8
Citigroup
New York
| $11K | +$3.44K | +6 | +86% |
|
9
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
VKH
10
Virtu KCG Holdings
New York
| – | -$31K | -74 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$1K | -2 | Closed |
|
KZIA Hedge Fund Activity: Q1 2015 in Review
9 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2015, worth a combined $897K — up 428% from $170K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KZIA positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $296K. The largest seller was Jane Street, cutting an estimated $93.5K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2015, up from 8 in Q4 2014.
- Funds reported $897K of Kazia Therapeutics stock for Q1 2015, up 428% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q1 2015 and 2 closed out, a net change of +1 holder.
- The largest Kazia Therapeutics buyer in Q1 2015 was Renaissance Technologies, an estimated $296K added.
- The largest Kazia Therapeutics seller in Q1 2015 was Jane Street, an estimated $93.5K sold.
Based on aggregated 13F filings for Q1 2015.